Reducing mortality from 2019-nCoV: host-directed therapies should be an option

Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality*
  • Coronavirus Infections / therapy
  • Drug Discovery
  • Global Health
  • Humans
  • Immunization, Passive
  • Pandemics
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2

Supplementary concepts

  • COVID-19 drug treatment
  • COVID-19 serotherapy